皮和脏替代疗法的危险因素在败血症冲击中
Lachlan H Donaldson1,2,3, Anthony Devaux1, Kyle C White4,5
1The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia.
JAMA network open
|May 27, 2025
概括
静脉注射的皮松降低了置换治疗 (KRT) 需要的风险,在患有败血性休克的患者中. 这种治疗对那些需要它的人来说没有显著影响活着和没有KRT的日子.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症相关的急性损伤 (SA-AKI) 是重症患者的重大并发症.
- 炎症在SA-AKI的发展和进展中起着关键作用.
- 静脉注射的皮正在研究其减轻SA-AKI进展的潜力.
研究的目的:
- 评估皮松剂的使用与脏替代疗法 (KRT) 需要发生率之间的关联性,对患有败血性休克的患者.
- 评估皮对KRT结果的影响,包括活着和没有KRT的日子.
- 探索使用皮,平均动脉压 (MAP) 和血管压缩剂支持之间的关系.
主要方法:
- 多中心,安慰剂控制的临床临床试验 (RCT) 随机分析后期分析,临床试验中临重病患有败血性休克 (ADRENAL) 的辅助皮质类固醇治疗.
- 包括3161名在随机化时不需要KRT的感染性休克患者.
- 数据分析的重点是比较皮质素接受者与安慰剂,检查KRT发生率和KRT释放.
主要成果:
- 与安慰剂相比,皮使用与KRT需求的发生率显著降低 (OR,0.79;P=.01).
- 在控制影响KRT要求的因素后,这种关联仍然很重要.
- 在启动KRT的患者中,皮质并没有显著改善活着和没有KRT的日子 (平均差异1.28天;P=.65).
结论:
- 静脉注射皮松与患有败血性休克的患者需要新置换治疗的可能性降低有关.
- 这项研究表明,皮在预防这种人群中需要KRT方面具有潜在的益处.
- 进一步的研究可能是有必要的,以探索皮在SA-AKI管理中的作用及其对长期恢复的影响.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
Acute Kidney Injury II: Pathophysiology
101
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
101
Acute Kidney Injury V: Interprofessional Care
52
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
52
Acute Kidney Injury I: Introduction
83
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
83
Acute Kidney Injury III: Clinical Manifestations
105
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
105
Renal Failure: Dose Adjustments
167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167


